SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-158772
Filing Date
2024-06-11
Accepted
2024-06-11 09:25:02
Documents
15
Period of Report
2024-06-11
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d824393d8k.htm   iXBRL 8-K 45684
2 EX-3.1 d824393dex31.htm EX-3.1 5618
3 EX-3.2 d824393dex32.htm EX-3.2 66513
  Complete submission text file 0001193125-24-158772.txt   265770

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA dcph-20240611.xsd EX-101.SCH 2856
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE dcph-20240611_lab.xml EX-101.LAB 17980
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dcph-20240611_pre.xml EX-101.PRE 11262
18 EXTRACTED XBRL INSTANCE DOCUMENT d824393d8k_htm.xml XML 3711
Mailing Address 200 SMITH STREET WALTHAM MA 02451
Business Address 200 SMITH STREET WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Filer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38219 | Film No.: 241034701
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)